| Medical and Health Sciences | Lifetime | 72 | IT 3 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 206 | IT 18 | 99.96 |
| Cardiology and Cardiovascular Medicine | Lifetime | 20 | IT 1 | 99.98 |
| Surgery | Lifetime | 586 | IT 22 | 99.46 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 260 | IT 15 | 99.21 |
| Nutrition and Dietetics | Lifetime | 248 | IT 8 | 98.84 |
| Complementary and Alternative Medicine | Lifetime | 268 | IT 8 | 98.69 |
| Family Practice | Lifetime | 74 | IT 1 | 95.75 |
| Endocrine and Autonomic Systems | Lifetime | 332 | IT 7 | 94.52 |
| Nephrology | Lifetime | 600 | IT 25 | 92.90 |
| Biochemistry | Lifetime | 850 | IT 21 | 82.20 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 39 | IT 3 | 99.85 |
| Surgery | 2021-2025 | 625 | IT 37 | 94.61 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 274 | IT 16 | 93.93 |
| Family Practice | 2021-2025 | 23 | IT 1 | 91.45 |
| Nephrology | 2021-2025 | 253 | IT 16 | 83.10 |
| Psychiatry and Mental health | 2021-2025 | 661 | IT 24 | 78.15 |
| Nutrition and Dietetics | 2021-2025 | 425 | IT 11 | 77.89 |
| Heart Rate Variability and Autonomic Control | Lifetime | 1 | IT 1 | 99.97 |
| Cardiovascular Health and Disease Prevention | Lifetime | 1 | IT 1 | 99.95 |
| Blood Pressure and Hypertension Studies | Lifetime | 3 | IT 1 | 99.96 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 2 | IT 1 | 99.87 |
| Hormonal Regulation and Hypertension | Lifetime | 15 | IT 1 | 99.81 |
| Sodium Intake and Health | Lifetime | 4 | IT 1 | 99.83 |
| Hemodynamic Monitoring and Therapy | Lifetime | 18 | IT 4 | 99.74 |
| Medication Adherence and Compliance | Lifetime | 12 | IT 1 | 99.50 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 114 | IT 6 | 99.65 |
| Non-Invasive Vital Sign Monitoring | Lifetime | 45 | IT 6 | 99.24 |
| Cardiovascular and exercise physiology | Lifetime | 99 | IT 5 | 99.41 |
| Neuroscience of respiration and sleep | Lifetime | 155 | IT 3 | 99.03 |
| COVID-19 Clinical Research Studies | Lifetime | 279 | IT 33 | 98.75 |
| Cardiovascular Disease and Adiposity | Lifetime | 130 | IT 2 | 99.26 |
| Cardiovascular Function and Risk Factors | Lifetime | 345 | IT 17 | 99.34 |
| Heart rate and cardiovascular health | Lifetime | 11 | IT 4 | 98.89 |
| Diabetes Treatment and Management | Lifetime | 229 | IT 18 | 99.05 |
| Cardiac Health and Mental Health | Lifetime | 151 | IT 3 | 98.62 |
| Pharmacology and Obesity Treatment | Lifetime | 95 | IT 6 | 98.72 |
| Nutritional Studies and Diet | Lifetime | 316 | IT 12 | 98.87 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 642 | IT 12 | 98.50 |
| Heart Failure Treatment and Management | Lifetime | 375 | IT 18 | 98.59 |
| Long-Term Effects of COVID-19 | Lifetime | 442 | IT 73 | 96.63 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 323 | IT 12 | 97.84 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 728 | IT 16 | 98.19 |
| Obstructive Sleep Apnea Research | Lifetime | 328 | IT 15 | 97.73 |
| Pharmaceutical Economics and Policy | Lifetime | 188 | IT 6 | 97.24 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 687 | IT 27 | 97.81 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 458 | IT 11 | 96.68 |
| Lipoproteins and Cardiovascular Health | Lifetime | 705 | IT 30 | 97.22 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 285 | IT 24 | 94.48 |
| Renin-Angiotensin System Studies | Lifetime | 593 | IT 17 | 95.02 |
| High Altitude and Hypoxia | Lifetime | 789 | IT 24 | 92.24 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 3 | IT 2 | 99.76 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 4 | IT 2 | 99.64 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 8 | IT 2 | 99.73 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 22 | IT 6 | 97.18 |
| Medication Adherence and Compliance | 2021-2025 | 28 | IT 3 | 96.43 |
| Hormonal Regulation and Hypertension | 2021-2025 | 52 | IT 3 | 97.56 |
| Sodium Intake and Health | 2021-2025 | 19 | IT 1 | 97.42 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 388 | IT 31 | 96.35 |
| Heart rate and cardiovascular health | 2021-2025 | 4 | IT 2 | 96.57 |
| Nutritional Studies and Diet | 2021-2025 | 453 | IT 32 | 94.77 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 237 | IT 22 | 92.42 |
| Cardiac Health and Mental Health | 2021-2025 | 285 | IT 13 | 91.92 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 986 | IT 131 | 94.04 |
| Alcohol Consumption and Health Effects | 2021-2025 | 385 | IT 20 | 87.16 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 306 | IT 29 | 81.74 |
| Pharmaceutical Economics and Policy | 2021-2025 | 429 | IT 19 | 82.48 |